These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 37507632)

  • 1. Atypical Localization of Eczema Discriminates DOCK8 or STAT3 Deficiencies from Atopic Dermatitis.
    Kasap N; Kara A; Celik V; Bilgic Eltan S; Akay Haci I; Kose H; Aygun A; Akkelle E; Yakici N; Guner SN; Reisli I; Keles S; Cekic S; Kilic SS; Karaca NE; Gulez N; Genel F; Ozen A; Yucelten AD; Karakoc-Aydiner E; Schmitz-Abe K; Baris S
    J Clin Immunol; 2023 Nov; 43(8):1882-1890. PubMed ID: 37507632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atopic dermatitis, STAT3- and DOCK8-hyper-IgE syndromes differ in IgE-based sensitization pattern.
    Boos AC; Hagl B; Schlesinger A; Halm BE; Ballenberger N; Pinarci M; Heinz V; Kreilinger D; Spielberger BD; Schimke-Marques LF; Sawalle-Belohradsky J; Belohradsky BH; Przybilla B; Schaub B; Wollenberg A; Renner ED
    Allergy; 2014 Jul; 69(7):943-53. PubMed ID: 24898675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A set of clinical and laboratory markers differentiates hyper-IgE syndrome from severe atopic dermatitis.
    Kasap N; Celik V; Isik S; Cennetoglu P; Kiykim A; Eltan SB; Nain E; Ogulur I; Baser D; Akkelle E; Celiksoy MH; Kocamis B; Cipe FE; Yucelten AD; Karakoc-Aydiner E; Ozen A; Baris S
    Clin Immunol; 2021 Feb; 223():108645. PubMed ID: 33301882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The extended clinical phenotype of 64 patients with dedicator of cytokinesis 8 deficiency.
    Engelhardt KR; Gertz ME; Keles S; Schäffer AA; Sigmund EC; Glocker C; Saghafi S; Pourpak Z; Ceja R; Sassi A; Graham LE; Massaad MJ; Mellouli F; Ben-Mustapha I; Khemiri M; Kilic SS; Etzioni A; Freeman AF; Thiel J; Schulze I; Al-Herz W; Metin A; Sanal Ö; Tezcan I; Yeganeh M; Niehues T; Dueckers G; Weinspach S; Patiroglu T; Unal E; Dasouki M; Yilmaz M; Genel F; Aytekin C; Kutukculer N; Somer A; Kilic M; Reisli I; Camcioglu Y; Gennery AR; Cant AJ; Jones A; Gaspar BH; Arkwright PD; Pietrogrande MC; Baz Z; Al-Tamemi S; Lougaris V; Lefranc G; Megarbane A; Boutros J; Galal N; Bejaoui M; Barbouche MR; Geha RS; Chatila TA; Grimbacher B
    J Allergy Clin Immunol; 2015 Aug; 136(2):402-12. PubMed ID: 25724123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Key findings to expedite the diagnosis of hyper-IgE syndromes in infants and young children.
    Hagl B; Heinz V; Schlesinger A; Spielberger BD; Sawalle-Belohradsky J; Senn-Rauh M; Magg T; Boos AC; Hönig M; Schwarz K; Dückers G; von Bernuth H; Pache C; Karitnig-Weiss C; Belohradsky BH; Frank J; Niehues T; Wahn V; Albert MH; Wollenberg A; Jansson AF; Renner ED
    Pediatr Allergy Immunol; 2016 Mar; 27(2):177-84. PubMed ID: 26592211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dominant-negative signal transducer and activator of transcription (STAT)3 variants in adult patients: A single center experience.
    Shamriz O; Rubin L; Simon AJ; Lev A; Barel O; Somech R; Korem M; Matza Porges S; Freund T; Hagin D; Garty BZ; Nahum A; Molho Pessach V; Tal Y
    Front Immunol; 2022; 13():1044933. PubMed ID: 36605204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dedicator of cytokinesis 8 regulates signal transducer and activator of transcription 3 activation and promotes T
    Keles S; Charbonnier LM; Kabaleeswaran V; Reisli I; Genel F; Gulez N; Al-Herz W; Ramesh N; Perez-Atayde A; Karaca NE; Kutukculer N; Wu H; Geha RS; Chatila TA
    J Allergy Clin Immunol; 2016 Nov; 138(5):1384-1394.e2. PubMed ID: 27350570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic challenge in a series of eleven patients with hyper IgE syndromes.
    Yaakoubi R; Mekki N; Ben-Mustapha I; Ben-Khemis L; Bouaziz A; Ben Fraj I; Ammar J; Hamzaoui A; Turki H; Boussofara L; Denguezli M; Haddad S; Ouederni M; Bejaoui M; Chan KW; Lau YL; Mellouli F; Barbouche MR; Ben-Ali M
    Front Immunol; 2022; 13():1057679. PubMed ID: 36703986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Large deletions and point mutations involving the dedicator of cytokinesis 8 (DOCK8) in the autosomal-recessive form of hyper-IgE syndrome.
    Engelhardt KR; McGhee S; Winkler S; Sassi A; Woellner C; Lopez-Herrera G; Chen A; Kim HS; Lloret MG; Schulze I; Ehl S; Thiel J; Pfeifer D; Veelken H; Niehues T; Siepermann K; Weinspach S; Reisli I; Keles S; Genel F; Kutukculer N; Camcioğlu Y; Somer A; Karakoc-Aydiner E; Barlan I; Gennery A; Metin A; Degerliyurt A; Pietrogrande MC; Yeganeh M; Baz Z; Al-Tamemi S; Klein C; Puck JM; Holland SM; McCabe ER; Grimbacher B; Chatila TA
    J Allergy Clin Immunol; 2009 Dec; 124(6):1289-302.e4. PubMed ID: 20004785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hyper-IgE syndromes].
    He YY; Liu B; Xiao XP
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jun; 31(11):892-896. PubMed ID: 29775011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyper IgE Syndromes.
    Gracci S; Novelli T; D'Elios S; Bernardini R; Peroni D
    Curr Pediatr Rev; 2024; 20(3):253-264. PubMed ID: 37702167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Profile of Hyper-IgE Syndrome in India.
    Saikia B; Rawat A; Minz RW; Suri D; Pandiarajan V; Jindal A; Sahu S; Karim A; Desai M; Taur PD; Pandrowala A; Gowri V; Madkaikar M; Dalvi A; Yadav RM; Lashkari HP; Raj R; Uppuluri R; Swaminathan VV; Bhattad S; Cyril G; Kumar H; Shukla A; Kalra M; Govindaraj G; Singh S
    Front Immunol; 2021; 12():626593. PubMed ID: 33717144
    [No Abstract]   [Full Text] [Related]  

  • 13. Regulatory T-cell dysfunction and cutaneous exposure to Staphylococcus aureus underlie eczema in DOCK8 deficiency.
    Wilkie H; Das M; Pelovitz T; Bainter W; Woods B; Alasharee M; Sobh A; Baris S; Eltan SB; Al-Herz W; Barbouche MR; Ben-Mustapha I; Ben-Ali M; Sallam MTH; Awad A; Lotfy S; El Marsafy A; Ezzelarab M; Farrar M; Schmidt BAR; NandyMazumdar M; Guttman-Yassky E; Sheets A; Vidic KM; Murphy G; Schlievert PM; Chou J; Leyva-Castillo JM; Janssen E; Timilshina M; Geha RS
    J Allergy Clin Immunol; 2024 Jul; 154(1):143-156. PubMed ID: 38185418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment options for DOCK8 deficiency-related severe dermatitis.
    Ollech A; Mashiah J; Lev A; Simon AJ; Somech R; Adam E; Barzilai A; Hagin D; Greenberger S
    J Dermatol; 2021 Sep; 48(9):1386-1393. PubMed ID: 34043252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Severe atopy and allergy--rare hyper-IgE syndrome caused by the DOCK8 mutation as underlying condition].
    Koskenvuo M; Kainulainen L; Vanto T; Lukkarinen H; Lähteenmäki P; Ruuskanen O
    Duodecim; 2015; 131(6):541-4. PubMed ID: 26237897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Severe atopic dermatitis caused by rare immunodeficiency in childhood].
    Wolsk HM; Marquart HV; Laub B; Gniadecki R; Nysom K; Ifversen M
    Ugeskr Laeger; 2015 Dec; 177(51):V06150498. PubMed ID: 26692033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical, immunological and molecular characterization of DOCK8 and DOCK8-like deficient patients: single center experience of twenty-five patients.
    Alsum Z; Hawwari A; Alsmadi O; Al-Hissi S; Borrero E; Abu-Staiteh A; Khalak HG; Wakil S; Eldali AM; Arnaout R; Al-Ghonaium A; Al-Muhsen S; Al-Dhekri H; Al-Saud B; Al-Mousa H
    J Clin Immunol; 2013 Jan; 33(1):55-67. PubMed ID: 22968740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous manifestations of DOCK8 deficiency syndrome.
    Chu EY; Freeman AF; Jing H; Cowen EW; Davis J; Su HC; Holland SM; Turner ML
    Arch Dermatol; 2012 Jan; 148(1):79-84. PubMed ID: 21931011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical, immunological, and genetic description of a Mexican cohort of patients with DOCK8 deficiency.
    Liquidano-Perez E; Maza-Ramos G; Perez Arias BA; Lugo Reyes SO; Barragan Arevalo T; Solorzano-Morales SA; Venegas Montoya E; Staines-Boone AT; Guzmán Cotaya R; Okada S; Picard C; Patin E; Ramirez-Uribe N; Bustamante-Ogando JC; Scheffler-Mendoza SC; Yamazaki-Nakashimada MA; Saez-de-Ocariz M; Espinosa Padilla SE; Gonzalez-Serrano ME
    Pediatr Allergy Immunol; 2024 Feb; 35(2):e14073. PubMed ID: 38351896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The first cohort of Iranian patients with hyper immunoglobulin E syndrome: A long-term follow-up and genetic analysis.
    Tavassoli M; Abolhassani H; Yazdani R; Ghadami M; Azizi G; Abdolrahim Poor Heravi S; Moeini Shad T; Kokabee M; Movahedi M; Abdshahzadeh H; Gharagozlou M; Rezaei N; Esmaeilzadeh H; Aleyasin S; Aghamohammadi A
    Pediatr Allergy Immunol; 2019 Jun; 30(4):469-478. PubMed ID: 30801830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.